Format

Send to

Choose Destination
Ginekol Pol. 2019;90(5):270-273. doi: 10.5603/GP.2019.0050.

Non-invasive prenatal testing for detection of trisomy 13, 18, 21 and sex chromosome aneuploidies in 8594 cases.

Author information

1
Department of Obstetrics and Gynecology, The First Affiliated Hospital Of AFMU (Air Force Medical University), Xi'an, Shaanxi, China.
2
Department of Obstetrics and Gynecology, The First Affiliated Hospital Of AFMU (Air Force Medical University), Xi'an, Shaanxi, China. jianfangzhang17@sina.com.

Abstract

OBJECTIVES:

Cell-free fetal DNA has been widely used in prenatal genetic testing during recent years. We explored the feasibility of non-invasive prenatal testing (NIPT) for analysis of common fetal aneuploidies among pregnancies in northwest China.

MATERIAL AND METHODS:

A total of 8594 maternal blood samples were collected from October 2014 to December 2017 in the Department of Obstetrics and Gynecology at the First Affiliated Hospital of the Air Force Medical University. Cases with positive screening results by NIPT detection were validated using karyotype analysis.

RESULTS:

Of 8594 clinical pregnancies, 88 had positive NIPT results and 78 of 88 (88.6%) positive NIPT results were shown to be false-positive by amniotic fluid puncture and chromosome karyotyping analysis. There were 44 cases (49.44%) with trisomy 21, 18, and 13 syndromes (30 cases of trisomy 21, 9 cases of trisomy 18, and 5 cases of trisomy 13). There were 44 cases (50.56%) with sex chromosome abnormalities, including 11 cases with Turner syndrome (45, X), 17 cases with Triple X syndrome (47, XXX), 2 cases with Klinefelter syndrome (47, XXY), and 14 cases with 47, XYY syndrome (47, XYY).

CONCLUSIONS:

The accuracy, specificity, high efficiency, and acceptance of NIPT can effectively avoid birth defects and improve the quality of the birth population. We should deepen mining and analysis of the clinical data and explore ways to use NIPT. It is recommended that the NIPT guidelines be extended to low-risk patients to further explore the impact of a significant increase in screening.

KEYWORDS:

fetal aneuploidy; karyotype analysis; non-invasive prenatal testing

PMID:
31165466
DOI:
10.5603/GP.2019.0050
Free full text

Supplemental Content

Full text links

Icon for Via Medica Medical Publishers
Loading ...
Support Center